Protagonist Therapeutics, Inc (PTGX) › Total AssetsProtagonist Therapeutics, Inc (PTGX) — Total AssetsAnnual figures by period end, from SEC filings.2015-12-31: $14.85M2016-12-31: $93.99M2017-12-31: $163.73M2018-12-31: $139.47M2019-12-31: $154.92M2020-12-31: $324.47M2021-12-31: $347.69M2022-12-31: $247.93M2023-12-31: $357.95M2024-12-31: $744.73M2025-12-31: $668.19M$668.19M2015-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$668.19M-10.3%2026-02-25Balance as of period end2024-12-31$744.73M+108.1%2026-02-25Balance as of period end2023-12-31$357.95M+44.4%2025-02-21Balance as of period end2022-12-31$247.93M-28.7%2024-02-27Balance as of period end2021-12-31$347.69M+7.2%2023-03-15Balance as of period end2020-12-31$324.47M+109.4%2022-02-28Balance as of period end2019-12-31$154.92M+11.1%2021-03-10Balance as of period end2018-12-31$139.47M-14.8%2020-03-10Balance as of period end2017-12-31$163.73M+74.2%2019-03-12Balance as of period end2016-12-31$93.99M+533.1%2018-03-07Balance as of period end2015-12-31$14.85M—2017-03-07Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)